These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9987153)

  • 1. A comparison of alternate immunization regimes for measles in vaccinated populations.
    Pabst HF; Boothe PM; Carson MM
    Vaccine; 1999 Jan; 17(2):182-92. PubMed ID: 9987153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel.
    Dagan R; Slater PE; Duvdevani P; Golubev N; Mendelson E
    Pediatr Infect Dis J; 1995 Nov; 14(11):965-9. PubMed ID: 8584363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.
    Ceyhan M; Kanra G; Erdem G; Kanra B
    Vaccine; 2001 Aug; 19(31):4473-8. PubMed ID: 11483273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants.
    Johnson CE; Darbari A; Darbari DS; Nalin D; Whitwell J; Chui LW; Cleves MA; Kumar ML
    Vaccine; 2000 May; 18(22):2411-5. PubMed ID: 10738098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal measles antibody decay in rural Bangladeshi infants--implications for vaccination schedules.
    de Francisco A; Hall AJ; Unicomb L; Chakraborty J; Yunus M; Sack RB
    Vaccine; 1998 Apr; 16(6):564-8. PubMed ID: 9569466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles elimination: old and new challenges?
    Muller CP
    Vaccine; 2001 Mar; 19(17-19):2258-61. PubMed ID: 11257344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles immunization strategy: measles antibody response following MMR II vaccination of children at one year of age.
    Ratnam S; West R; Gadag V; Burris J
    Can J Public Health; 1996; 87(2):97-100. PubMed ID: 8753636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.
    Gagneur A; Pinquier D; Aubert M; Balu L; Brissaud O; De Pontual L; Gras Le Guen C; Hau-Rainsard I; Mory O; Picherot G; Stephan JL; Cohen B; Caulin E; Soubeyrand B; Reinert P
    Clin Vaccine Immunol; 2008 Dec; 15(12):1845-50. PubMed ID: 18815232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants.
    Pabst HF; Spady DW; Carson MM; Krezolek MP; Barreto L; Wittes RC
    Vaccine; 1999 Apr; 17(15-16):1910-8. PubMed ID: 10217589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles.
    De Serres G; Joly JR; Fauvel M; Meyer F; Mâsse B; Boulianne N
    Vaccine; 1997; 15(6-7):620-3. PubMed ID: 9178461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.
    Guerra FM; Crowcroft NS; Friedman L; Deeks SL; Halperin SA; Severini A; Hatchette TF; Bolotin S;
    Vaccine; 2018 Feb; 36(10):1248-1255. PubMed ID: 29398276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
    Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
    Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles antibodies in women and infants in the vaccine era.
    Kacica MA; Venezia RA; Miller J; Hughes PA; Lepow ML
    J Med Virol; 1995 Feb; 45(2):227-9. PubMed ID: 7775944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protecting infants against measles in England and Wales: a review.
    Manikkavasagan G; Ramsay M
    Arch Dis Child; 2009 Sep; 94(9):681-5. PubMed ID: 19457878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity against measles in populations of women and infants in Poland.
    Janaszek W; Slusarczyk J
    Vaccine; 2003 Jun; 21(21-22):2948-53. PubMed ID: 12798638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.